Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Astragalin (Kaempferol-3-O-glucoside).
A flavonoid glycoside primarily recognized for its potent anti-inflammatory, antioxidant, and anti-allergic properties mediated through the inhibition of NF-κB and MAPK signaling pathways.
5282102
448.4 g/mol
0.7
5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one
Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Astragalin (Kaempferol-3-O-glucoside) across standard consumer modalities.
Astragalin's hygroscopic nature requires moisture-controlled environments to prevent clumping and ensure consistent dissolution rates in hard-shell capsules.
The molecule's sensitivity to high thermal processing temperatures during pectin gelation can lead to oxidative degradation and loss of potency.
Low aqueous solubility and a relatively high effective dose create significant payload challenges for the limited polymer matrix volume of thin-film strips.
Ready to launch a product featuring Astragalin (Kaempferol-3-O-glucoside)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.
Build Science-Backed FormulationNeed absolute proof that your Astragalin (Kaempferol-3-O-glucoside) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.
Simulate BioavailabilityIs your Astragalin (Kaempferol-3-O-glucoside) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.
Model Active Degradation